0
0.0
Feb 6, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
i also own lily, but you can own amgen. it's very expensive and overextended when you talk about relative strength index. it has a level of 77. >> so basically own them all if i hear you right. >> i think so. >> finally, uber. uber has been on an uber run. they're also watching lyft, because apparently app downloads for lyft have lifted. so jeff, with uber, has that stock run up too much for you or still valued here? >> pump the brakes, sully. you have to look at 150% in 2023, off to a great start, up today. so you have to take profits. if you still own it, you can be cautious and put on option joef lay. but the incentives that they need to give their drivers globally, that's a head wind. i think you can think their market expenses because more of a head wind as they fight lyft. i'm a seller here. it z so pump those brakes. >> overall, jeff, i want to get your macro market take. it's been a pretty good start to the year, magnificent seven, minus tesla, of course, has done very well. you just heard the previous guest say tha
i also own lily, but you can own amgen. it's very expensive and overextended when you talk about relative strength index. it has a level of 77. >> so basically own them all if i hear you right. >> i think so. >> finally, uber. uber has been on an uber run. they're also watching lyft, because apparently app downloads for lyft have lifted. so jeff, with uber, has that stock run up too much for you or still valued here? >> pump the brakes, sully. you have to look at 150% in...
0
0.0
Feb 8, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen shedding 9% so far this week after giving trial data from its weight loss drug.ng patients lost 14.5% in their body weight in 12 weeks, with the monthly injection. with many keeping off the weight after stopping treatment. still, our next guest is skeptical that the drug can meet the high bar set by novo nordisk and eli lilly. jared holz, 14.5% is fantastic, but when you compare it to the percentage of weight that you can lose on the other drugs, it doesn't stack up, not to mention that so many participants in the trial had to drop out at the higher doses. do you sort of write off that amgen obesity drug part of the story? should we give up on that? >> well, melissa, i think it's too early to give up completely. you know, there's a lot of data that's yet to come out from the company. but just from what we've learned early on about the high dose and the dropout rate being fairly high, almost 50%, i think the company just has a lot to prove in this category, and it's not like the drug is disinteresting or the data is super disappointing, but when you kind of juxtap
amgen shedding 9% so far this week after giving trial data from its weight loss drug.ng patients lost 14.5% in their body weight in 12 weeks, with the monthly injection. with many keeping off the weight after stopping treatment. still, our next guest is skeptical that the drug can meet the high bar set by novo nordisk and eli lilly. jared holz, 14.5% is fantastic, but when you compare it to the percentage of weight that you can lose on the other drugs, it doesn't stack up, not to mention that...
0
0.0
Feb 12, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >> finally, an amgen and one of the biggest biotechs in the world.hole, david, are pretty interesting because they used to be the n vividias of a certain way and nobody seems to care about biotechs lately and maybe that's the point. >> definitely not the big biotechs. they sell as if they were drug companies. in terms of amgen they've done very well as a business and the stock sells at 14 times earnings and the stock's down after a glittering report. they have a number of goals on the weight loss drugs and they're clearly not a lily or novo nor disk, but we believe they have the next generation of products and instead of playing 18 times for lily, you are paying for amgen which might have a product out there and you're getting a very low yield while you're waiting and it makes mono sdpey and grows over. >> and david katz, matrix asset advisers. also a pleasure. >> thanks a lot. have a great day. >> so if you're an investor when stocks go up it's likely your wealth goes up, too, and one group has seen the value of your assets by 50%, 5-0 percent in le
. >> finally, an amgen and one of the biggest biotechs in the world.hole, david, are pretty interesting because they used to be the n vividias of a certain way and nobody seems to care about biotechs lately and maybe that's the point. >> definitely not the big biotechs. they sell as if they were drug companies. in terms of amgen they've done very well as a business and the stock sells at 14 times earnings and the stock's down after a glittering report. they have a number of goals on...
0
0.0
Feb 27, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen is going further away.ey had a once a month injectable and they thought they had a pill. everything that viking has dave is working on at lil and has something. phase two is very, very hard, very expensive. >> so while investors may be joysing at viking's science. >> unless pfizer comes on and buys them which is unlikely. >> i don't know. you never know. get into the weight loss drug -- >> you never know. it's a very exciting category, and a lot of companies want to be in it. people have to understand i've worked with the fda. the fda, once you have a drug, they're not -- they take their time with the second sddrug. >> there's a therapy out there they don't need to rush. >> when working on a migraine, they wanted to have the word out. i find the fda to be incredibly responsible. >> real quick, what do we have on the program today? >> him and hers up very big, and i'm trying to figure out how much of that is weight loss. they have weight loss, they have healthy sex life. i'll have the guy on. >> why not. all
amgen is going further away.ey had a once a month injectable and they thought they had a pill. everything that viking has dave is working on at lil and has something. phase two is very, very hard, very expensive. >> so while investors may be joysing at viking's science. >> unless pfizer comes on and buys them which is unlikely. >> i don't know. you never know. get into the weight loss drug -- >> you never know. it's a very exciting category, and a lot of companies want...
0
0.0
Feb 1, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen, boeing, caterpillar, ulta, you happen to own martin marietta >> i do. >> touch on that first >> i like the commodity price. we're going to do more infrastructure, the stock has done well and continues to do well >> do you like any names on this list there are some blue chip names, they still say are hidden in plain sight. all of these stocks haven't done quite well this year except for amgen is out of the gate pretty well this year >> they don't seem hidden to me. i've never liked the idea of buying a stock where you basically have to bet on the global economy heespecially aftr central bank tightening and quantitative tightening. a lot of the names qualify for that kind of idea. it's not a great list for me mcdonald's is interesting. it will be interesting to see if they can get traction in the snack day part but that's not going to move the needle for probably ten years >> i think it could be interesting if the economy starts slowing down. it has good operating margins. >> do you think it could be defensive, still operate that way? >> the movement from going out to eat will th
amgen, boeing, caterpillar, ulta, you happen to own martin marietta >> i do. >> touch on that first >> i like the commodity price. we're going to do more infrastructure, the stock has done well and continues to do well >> do you like any names on this list there are some blue chip names, they still say are hidden in plain sight. all of these stocks haven't done quite well this year except for amgen is out of the gate pretty well this year >> they don't seem hidden...
0
0.0
Feb 27, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
stuart: show me amgen, please. it's harply lower. a chunk of the dow's 105-point loss. health care in general is the largest drag on the dow. >>> okay, the overall markets9, not that much movement 12 minutes n. dow's down 1000, s&p down -- 100, s&p down 3. donald trump and nikki haley face off in the michigan pri may. grady trimble is in bloomfield. what are the voters telling you? >> reporter: stu, one of the most important issues for progress i voters and a real test for president biden here in michigan is his handling of the war many gauze what saw -- gaza. for republicans though, it's all about the economy, crime and all the a way up here near the canadian border, stu, immigration. finish. >> they're moving all over the country. there's no such thing as a only a border state anymore. we're all border states now. and they are coming from the north border also. >> there's no process left. it's uncontrolled and unvetted really. >> reporter: former president trump is counting on voters like those as well as blue collar workers to car
stuart: show me amgen, please. it's harply lower. a chunk of the dow's 105-point loss. health care in general is the largest drag on the dow. >>> okay, the overall markets9, not that much movement 12 minutes n. dow's down 1000, s&p down -- 100, s&p down 3. donald trump and nikki haley face off in the michigan pri may. grady trimble is in bloomfield. what are the voters telling you? >> reporter: stu, one of the most important issues for progress i voters and a real test...
0
0.0
Feb 27, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the bigger cap names, a lot of cash in there, amgen, which has exposure. >> funny, you know, you all make great points about stuff that's going on -- >> where's the but? >> but the but is that this looks like really late stage sort of market stuff. so, i look at my screens today and i see the ten-year at 4.3%, high yield has not always been a great thing for bio tech stocks, hasn't been great for small cap stocks. a lot of those bee owe techs are in the russell 2,000. that outperformed on a day that the s&p was basically unchanged. i have a whole page of broken spac deals -- >> oh. >> they're all raging today. this is not really bullish activity in my opinion, when i see the market kind of broadening out to that sort of stuff, so, you know, we can spend the next few days, every day, probably talking about a new thing that's going bat -- >> whoa, whoa, i'm sorry, i didn't mean it like that. >> one way to enmmean it. >> this is kind of how we talk on a trading desk, i did not mean to do it like that, but we can do that, but that's going to happen, so, here's today -- >> the flip side t
the bigger cap names, a lot of cash in there, amgen, which has exposure. >> funny, you know, you all make great points about stuff that's going on -- >> where's the but? >> but the but is that this looks like really late stage sort of market stuff. so, i look at my screens today and i see the ten-year at 4.3%, high yield has not always been a great thing for bio tech stocks, hasn't been great for small cap stocks. a lot of those bee owe techs are in the russell 2,000. that...
0
0.0
tv
eye 0
favorite 0
quote 0
the firm is concerned that poor test trial results from amgen's new weight loss drug candidate mean itight loss medicine space. the biowith pharmaceutical company did beat fourth quarter profit estimates after its acquisition is of horizon therapeutics, but the stock is pulling back by 5.5%. a sunnier outlook for solar energy company enphase energy. it is blasting to the top of the s&p with a gain of 16.333%. the company said it expects demand to improve through 2024, so oppenheimer raised its rating from perform to outperform, and ever core jumped in raising its price target from $115 to $125. the stock's at $117 even. >>> snap though, as we mentioned, tanking at the moment, down 34.9% after reporting that it missed on revenue estimates for the fourth quarter. that the marks the sixth straight quarter of single-digit growth. the social media company also forecasts larger than expected losses for the first quarter as it struggles to compete for ad dollars. the parent of snapchat has not rebounded from a slow 2022 advertising market and, of course, peer meta has done brilliantly. so wha
the firm is concerned that poor test trial results from amgen's new weight loss drug candidate mean itight loss medicine space. the biowith pharmaceutical company did beat fourth quarter profit estimates after its acquisition is of horizon therapeutics, but the stock is pulling back by 5.5%. a sunnier outlook for solar energy company enphase energy. it is blasting to the top of the s&p with a gain of 16.333%. the company said it expects demand to improve through 2024, so oppenheimer raised...
0
0.0
Feb 23, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
and apple at the very bottom -- sorry, amgen, amgen at the very top and, of course, apple at the very. ♪ ♪ clinic, we pride ourselves on putting others first. it's on us to help care for our clients' well-being; to help them adapt. it's inspiring to work at a place where our patients succeed. and we as therapists do, too. with great benefits from principal, we feel appreciated for the work we do. (♪) moving forward with node-positive breast cancer is overwhelming. but i never just found my way; i made it. and did all i could to prevent recurrence. verzenio reduces the risk of recurrence of hr-positive, her2-negative, node-positive, early breast cancer with a high chance of returning as determined by your doctor when added to hormone therapy. diarrhea is common, may be severe, or cause dehydration or infection. at the first sign, call your doctor, start an anti-diarrheal , and drink fluids. before taking verzenio, tell your doctor about any fever, chills, or other signs of infection. verzenio may cause low white blood cell counts, which may cause serious infection that can lead to deat
and apple at the very bottom -- sorry, amgen, amgen at the very top and, of course, apple at the very. ♪ ♪ clinic, we pride ourselves on putting others first. it's on us to help care for our clients' well-being; to help them adapt. it's inspiring to work at a place where our patients succeed. and we as therapists do, too. with great benefits from principal, we feel appreciated for the work we do. (♪) moving forward with node-positive breast cancer is overwhelming. but i never just found...
0
0.0
Feb 28, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
you mentioned amgen? how about others?ate stage phase two, also zeeland, a company that is a recent metabolic mash data last week. there is also the oral compounds, structure therapeutics, which has data coming up, and there is other interesting modalities that are people are trying to do beyond just glp, melissa. one of those is scala rock, regeneron and scala rock are working on myo statins. some of these drugs improve on losing muscle. there is other small companies like ventix, which works on antiinflammatories. a lot of different companies beyond lilly that i think over this ten years i think are going to be important. >> it seems like it would be an easy acquisition for big pharma to make because they're searching for ways to extend their pipeline, a lot of cash on the balance sheet, a lot of pressure to do something, when you look at the stock price. who do you think are likely candidates for acquisition? >> well, first i would say roche and astrazeneca both made smaller acquisitions over the past few months. i thin
you mentioned amgen? how about others?ate stage phase two, also zeeland, a company that is a recent metabolic mash data last week. there is also the oral compounds, structure therapeutics, which has data coming up, and there is other interesting modalities that are people are trying to do beyond just glp, melissa. one of those is scala rock, regeneron and scala rock are working on myo statins. some of these drugs improve on losing muscle. there is other small companies like ventix, which works...
0
0.0
Feb 21, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
number of companies that joined the dow back in august of 2020 they include salesforce honeywell, and amgenwhat does that say to you? >> yeah, it's interesting to me because iagree with you. lock, it may not mean anything to the fundamentals, but if you remember when tesla did a share split, it shouldn't have dub anything to the fundamentals, but it did, and i think this is the same type of thing we live in a world where passive inclusion is very important. what you have is some people have the ability to buy it or have some need to get exposure to it and the more important it becomes. the reason i believe dow jones included it is because they did not have these names to me what happens is you're going to get more concentration of the seven names where so much wealth is held they know extremes of the market i want to come back to you when it comes to the whole mag nif sejts 7, not just nvidia what are you continuing to see in the options market? >> what we're continuing to see is the call buys i want to be clear this doesn't necessarily mean people are quite bullish i think what it could al
number of companies that joined the dow back in august of 2020 they include salesforce honeywell, and amgenwhat does that say to you? >> yeah, it's interesting to me because iagree with you. lock, it may not mean anything to the fundamentals, but if you remember when tesla did a share split, it shouldn't have dub anything to the fundamentals, but it did, and i think this is the same type of thing we live in a world where passive inclusion is very important. what you have is some people...
0
0.0
Feb 1, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen has a phase one drug with less frequent administration >> tiffany, we have to leave it there.one more quick look at futures in the green across the bod.ar that will do it for us "squawk box" is up next. [innogue] another destination wedding? why can't they use my backyard?! with empower, we get all of our financial questions answered. so we don't have to worry. empower what's next. in order for small businesses to thrive, they need to be smart, efficient, savvy. making the most of every opportunity. that's why comcast business is introducing the small business bonus. for a limited time you can get up to $1000 prepaid card with qualifying internet. yup, $1000. so switch to business internet from the company with the largest fastest reliable network. give your business a head start in 2024 with this great offer. plus, ask how to get up to $1000 prepaid card with qualifying internet. >>> good morning events in washington impacting the world of business this morning. we will talk about fed chairman jay powell taking a march rate cut off the table. the futures rebounding somewhat a
amgen has a phase one drug with less frequent administration >> tiffany, we have to leave it there.one more quick look at futures in the green across the bod.ar that will do it for us "squawk box" is up next. [innogue] another destination wedding? why can't they use my backyard?! with empower, we get all of our financial questions answered. so we don't have to worry. empower what's next. in order for small businesses to thrive, they need to be smart, efficient, savvy. making the...
0
0.0
Feb 7, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
we've talked so much about it, as you see, nvidia but eli lilly also up another 2.6% amgen has a potentialit does not appear in the early going to have the same efficacy in taerms terms of the overall weight loss as mounjaro. so lily shares down. >> we had a long conversation yesterday about sort of the analog between chips and ai and demand and you heard the adam parker a moment ago say, we're in the batters' box, not even in the first inning and the production of these drugs, which hasn't even gotten to the middle of the country where you could argue obesity is at its most acute. >> the trends that capture the imagination of 2023 are working again, seemingly, this year. ai, the obesity -- we thought this year was going to be different, because it was going to be a broadening out, but the russell 2000 is down for the year and has underperformed. and that was one of the big calls on the street, is that we were going to get small caps, because the economy is better, and the fed will be cutting race >> and we haven't gotten the rate cuts. >> no, they're getting pushed out. >> the russell is
we've talked so much about it, as you see, nvidia but eli lilly also up another 2.6% amgen has a potentialit does not appear in the early going to have the same efficacy in taerms terms of the overall weight loss as mounjaro. so lily shares down. >> we had a long conversation yesterday about sort of the analog between chips and ai and demand and you heard the adam parker a moment ago say, we're in the batters' box, not even in the first inning and the production of these drugs, which...
0
0.0
Feb 26, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
honeywell and amgen under performing the blue chip index and the market.er addition to the dow transports with jason seidel. jason, good morning. >> great to be here. >> jason, adding ride share to the dow transports. is that a meaningful addition? >> i think it makes the pre predictability of the model better. right now, we are focused on the freight sector and what freight tells us about the economy going forward. >> speaking of the freight sector, you downgraded earnings estimates for the sector for trucking and rail. what led you to do that and what do you see that would lead you to downgrade estimates? >> we really took estimates down for everything but the less than truckload sector. if you look at the expectation for demand this year, it is muted in the first half of the year. everyone is looking for that back half turn around. i should point out that is not just the public companies, but when you look at the surveys we put out in the rail and trucking sector, the private companies are looking for a back half turn around. everybody is pushing expect
honeywell and amgen under performing the blue chip index and the market.er addition to the dow transports with jason seidel. jason, good morning. >> great to be here. >> jason, adding ride share to the dow transports. is that a meaningful addition? >> i think it makes the pre predictability of the model better. right now, we are focused on the freight sector and what freight tells us about the economy going forward. >> speaking of the freight sector, you downgraded...
0
0.0
Feb 12, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen, verizon, disney and chevron are the leaders. we'll see you tomorrow. ♪.he warning bell for nato countries wh
amgen, verizon, disney and chevron are the leaders. we'll see you tomorrow. ♪.he warning bell for nato countries wh
0
0.0
Feb 8, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
there's a huge amount that if you drink two drinks a night, and you get cirohsis of the liver -- >> amgenas not as powerful. >> we did not talk about that enough. the ceo of amgen did not -- >> lilly and novo have the lock on this market. >> we could have the industrials leading us. we could have the alternate energy leading us, and we could have -- >> wynn or ralph. >> by the way, ralph lauren is timeless. >> we're going to get to all of the movers, a lot of them in the consumer space. there's paypal, mattel, ralph and under armour, hershey, tapestry. look at the premarket as we continue to keep our eyes on s&p 5k. back in a moment. fresh, warm hot dogs! when i'm not selling hot dogs, i invest in a fund that advances innovations like robotics. fresh, warm hot dogs, straight out of my torso! one for you, one for you. oh, you're a messy one. cool, right? so cool. anyone can become an agent of innovation with invesco qqq, a fund that gives you access to nasdaq-100 innovations. hot dogs! fresh, warm hot dogs! before investing carefully read and consider fund investment objectives, risks, cha
there's a huge amount that if you drink two drinks a night, and you get cirohsis of the liver -- >> amgenas not as powerful. >> we did not talk about that enough. the ceo of amgen did not -- >> lilly and novo have the lock on this market. >> we could have the industrials leading us. we could have the alternate energy leading us, and we could have -- >> wynn or ralph. >> by the way, ralph lauren is timeless. >> we're going to get to all of the movers, a...
0
0.0
Feb 27, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
at the bottom we've got amgen, down 2.6%.ht back with a very important interview on the kroeger-albertson's potential merger. ♪ ♪ not you. you! your business bank account with quickbooks money now earns 5% apy. (♪) that's how you business differently. intuit quickbooks. they're waiting for you. hey, do you have a second? they're all expecting more. more efficiency. more benefits. more growth. when you realize you can give your people everything, and more. thank you very much. [applause] ask, "now what?" here's what. you go with prudential to protect, empower and grow. with everything you need to deliver, you guessed it... more. one more thing... who's your rock? learn more at prudential.com jorge has always put the ones he loves first. but when it comes to caring for his teeth he's let his own maintenance take a back seat. well maybe it's time to shift gears on that. because aspen dental has the latest technology and equipment. with a staff that goes out of their way to provide exceptional care. plus free exams and x-rays for
at the bottom we've got amgen, down 2.6%.ht back with a very important interview on the kroeger-albertson's potential merger. ♪ ♪ not you. you! your business bank account with quickbooks money now earns 5% apy. (♪) that's how you business differently. intuit quickbooks. they're waiting for you. hey, do you have a second? they're all expecting more. more efficiency. more benefits. more growth. when you realize you can give your people everything, and more. thank you very much. [applause]...
0
0.0
Feb 22, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
normal person without a computer science degree these companies will compete with the likes of merck and amgeni meanwhile, the sheer number of new data centers and factories using these new technologies will create trillions of dollars in value as the current data centers are outmoded while many new ones need to be built. we'll get to a whole new pc cycle that all the chipmakers have been waiting for. who else wins? how about outfits like vertiv with the wiring of a data center the lifeblood if you will. or eaton a maker of machinery that can be used to great effect charitable trust name. or even caterpillar with its largest vertical helping to create a foundation of these hulking monsters filled with grace hopper machines of huge size meanwhile, sovereign ai will almost certainly be a business in each country even if that business doesn't exist yet nations need to preserve their own culture and own language not be held back by machines trained using mainly english data sets. of course the luddites who fight against this new industrial revolution do have a toe to stand on because yes, some squ
normal person without a computer science degree these companies will compete with the likes of merck and amgeni meanwhile, the sheer number of new data centers and factories using these new technologies will create trillions of dollars in value as the current data centers are outmoded while many new ones need to be built. we'll get to a whole new pc cycle that all the chipmakers have been waiting for. who else wins? how about outfits like vertiv with the wiring of a data center the lifeblood if...
0
0.0
Feb 5, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
>> yeah, so, i would say amgen has some data that people are excited to see this year.ompany. roche is working on products, they said it could be one of the best in-class products. pfizer is working on an oral product. they did not show success in the first round, it wasn't success, but it wasn't a great tolerability. so, they are coming back with more data they'll show sometime in the first half of this year. >> louise, thank you for phoning in, appreciate it. louise chen. $630 price target on lilly. >> she's been, i mean, good for her, number one. the move happened over the last couple of weeks. we loved lilly collectively. it's $700 now, given the run it's had into earnings. you're playing at the deep end of the pool. with that said, i thought the same thing about facebook last week and that clearly was wrong, as well. market's right now rewarding excellence and lilly's been in that mode, and they are probably setting up for a stock split. the last one was in '97. and maybe entrance into the dow, as well. >> we said this so many times, in terms of, a point you made,
>> yeah, so, i would say amgen has some data that people are excited to see this year.ompany. roche is working on products, they said it could be one of the best in-class products. pfizer is working on an oral product. they did not show success in the first round, it wasn't success, but it wasn't a great tolerability. so, they are coming back with more data they'll show sometime in the first half of this year. >> louise, thank you for phoning in, appreciate it. louise chen. $630...
0
0.0
Feb 23, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen, american express.nvidia -- lauren: 820 for nvidia. stuart: look at that, up another 4 percent. copart, palo alto network coming back a bit, 2%. how about nasdaq winners? that's a nice list. nvidia, copart, zscaler, palo alto, zoom video. how about that? where's the yield on the 10-year treasuriesome kind of forgotten about that. it's at 4.31%. gold, well, how many people are buying gold bars right now? it's up $3 an ounce at $2,034. bitcoin, not exactly out of favor but not rallying either. $51,000 a coin. oil, mid 70s, $76.92 per barrel. show me nvidia, gotta have a look at that again. $819 right now, up another 4%. 16% yesterday, 4% today, 20% in a day and one hour. the average price for a gallon of regular, $3.26. actually it's down one cent. diesel, $409. >>> all right -- 4.09. coming up, good friend of the show dave portnoy just rescued a pit bull named miss peaches, and she's already gotten into trouble. roll it. >> miss peaches, are you now naughty? you ate my wallet? miss peaches, you ate my wa
amgen, american express.nvidia -- lauren: 820 for nvidia. stuart: look at that, up another 4 percent. copart, palo alto network coming back a bit, 2%. how about nasdaq winners? that's a nice list. nvidia, copart, zscaler, palo alto, zoom video. how about that? where's the yield on the 10-year treasuriesome kind of forgotten about that. it's at 4.31%. gold, well, how many people are buying gold bars right now? it's up $3 an ounce at $2,034. bitcoin, not exactly out of favor but not rallying...
0
0.0
Feb 28, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen, caterpillar, verizon and home depot., first solar,rage atlanta, nrg energy. money of them big names. nasdaq composite, same story. constellation energy. tesla's on the list, back above $200 a share. ross stores and meta platforms is on that list. getting close to $500 a share on that. how about that? >>> coming up, take a look at this op-ed. biden and democrats will do anything to stay in the white house. liz peek wrote it, and he's here to tell us the three tracks -- she's here to tell us the three tracks they plan to use to keep the executive branch. >>> trump defeeted -- defeated haley in michigan moving closer to a general election rematch against biden, but haley says she's sticking around through super tuesday. what is her goal here? >> the mayor of eric adams doubled down on calls to change the city's sanctuary status. how long before he can actually do the job is and deport criminals? new york city council minority leader joe borelli on that next. ♪ investment opportunities are everywhere you turn. do you charge
amgen, caterpillar, verizon and home depot., first solar,rage atlanta, nrg energy. money of them big names. nasdaq composite, same story. constellation energy. tesla's on the list, back above $200 a share. ross stores and meta platforms is on that list. getting close to $500 a share on that. how about that? >>> coming up, take a look at this op-ed. biden and democrats will do anything to stay in the white house. liz peek wrote it, and he's here to tell us the three tracks -- she's here...
0
0.0
Feb 12, 2024
02/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen, verizon, disney and chevron are the leaders. we'll see you tomorrow. ♪.arry: hello, folks, welcome to "kudlow," i'm larry kudlow. so former president trump rang the warning bell for nato countries who still don't pay their mandated share. by the way, non-payers include germany, france, italy and canada. we've got senator marco rubio will join us and respond to all of that in just a few moments. and then senator tommy tuberville will be here to talk about why it's a good idea or at least it's not a bad idea to negotiate with vladmir putin once in a while, and a bad idea to spend another $60 billion for ukraine. later in the show mazey pilup, a ethiopia jewish immigrant, legal immigrant, who was once a israeli idf paratrooper, running for congress in long island in a raise tomorrow that is all about securing our borders. what a big race that is. oh, by the way if anybody cares, joe biden's budget is borrowing us into bankruptcy. i don't know if anybody cares but we are a business show. first up let's go straight to our own edward lawrence who is standing by
amgen, verizon, disney and chevron are the leaders. we'll see you tomorrow. ♪.arry: hello, folks, welcome to "kudlow," i'm larry kudlow. so former president trump rang the warning bell for nato countries who still don't pay their mandated share. by the way, non-payers include germany, france, italy and canada. we've got senator marco rubio will join us and respond to all of that in just a few moments. and then senator tommy tuberville will be here to talk about why it's a good idea...
0
0.0
Feb 12, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >> it's a brand-new regime, and amgen didn't have what they thought they did, so it makes it so theven bigger, and lilly is -- you have to have foundries. >> and novo. >> novo doesn't have enough money, but novo is real. >> spending all that money last week to buy the manufacturing. >> that was smart, but they're very checkered manufacturing abilities. >> yes. there were some questions there. but why are you questioning their ability at novo in terms of factories? >> you have to spend a fortune. insulin was their main drug. and lilly cut the price of insulin, which therefore made it so that novo didn't have enough money, but main thing is expertise. you've got to build these factories really quickly, and then the pen, and whether or not you can have the pen, can have four shots in it or whether you have to develop four different pens, and if that's the case, then there's a pen shortage. >> do you want to do -- >> there is. >> gilead m&a. >> pen shortage? >> yes. i think we should do f.a.n.g. because i thought that endeavor was a talent agency. >> well, it is. it is. also owner of tk
. >> it's a brand-new regime, and amgen didn't have what they thought they did, so it makes it so theven bigger, and lilly is -- you have to have foundries. >> and novo. >> novo doesn't have enough money, but novo is real. >> spending all that money last week to buy the manufacturing. >> that was smart, but they're very checkered manufacturing abilities. >> yes. there were some questions there. but why are you questioning their ability at novo in terms of...
0
0.0
Feb 20, 2024
02/24
by
CNBC
tv
eye 0
favorite 0
quote 0
intel pg, chevron and amgen.eet" when we come back. to duckduckgo on all your devie duckduckgo comes with a built-n engine like google, but it's pi and doesn't spy on your searchs and duckduckgo lets you browse like chrome, but it blocks cooi and creepy ads that follow youa from google and other companie. and there's no catch. it's fre. we make money from ads, but they don't follow you aroud join the millions of people taking back their privacy by downloading duckduckgo on all your devices today. a car is a car... join the millions of people taking bis a spa. privacy an office. hi! hello! a cinema. so automated. yes, the definition of a car changes... but one thing stays the same. it's a mercedes-benz. ld z . >>> time for cramer's mad dash as we count down to the opening bell. industrials from evercore. >> this evercore call, it's really important when you downgrade caterpillar, you're downgrading the king. ingersoll rand no slouch, the other downgrade. this is more of a valuation -- let's say don't want to lose
intel pg, chevron and amgen.eet" when we come back. to duckduckgo on all your devie duckduckgo comes with a built-n engine like google, but it's pi and doesn't spy on your searchs and duckduckgo lets you browse like chrome, but it blocks cooi and creepy ads that follow youa from google and other companie. and there's no catch. it's fre. we make money from ads, but they don't follow you aroud join the millions of people taking back their privacy by downloading duckduckgo on all your devices...